Clinical results of sheath-based bypass system-assisted thoracic endovascular aortic repair with in-situ laser fenestration for aortic arch disease

彭智猷,金剑,叶开创,仇鹏,陆信武
DOI: https://doi.org/10.3760/cma.j.cn101411-20211228-00103
2022-01-01
Abstract:Objective:To investigate the efficacy and safety of thoracic endovascular aortic repair (TEVAR) combined with in-situ laser fenestration (ISLF) in the treatment of aortic arch lesions and analyze the clinical outcomes of maintaining cerebral perfusion during operation by temporary sheath-based bypass system.Methods:From January 2017 to December 2019, clinical data of 61 patients who underwent TEVAR combined with ISLF in the Shanghai Ninth people's Hospital Affiliated to Shanghai Jiaotong University School of Medicine to receive endovascular repair involving aortic arch lesions, and maintain cerebral perfusion through temporary shunt applied to supra-aortic artery by using vascular sheathwere retrospectively analyzed, including 25 cases of Stanford type A aortic dissection, 8 cases of Stanford type B aortic dissection, 9 cases of intramural hematoma, 5 cases of penetrating ulcer, and 14 cases of aortic aneurysm. The technical success rate, aortic remodeling, patency of branch stents, and incidence of neurological complications were evaluated.Results:Among 61 patients, 47 cases underwent fenestration and reconstruction of three supra-aortic branches, and 14 cases of two branches, with a technical success rate of 100%. 4.9% of the patients (3/61) had transient stroke symptoms after operation. One case died due to acute myocardial infarction during hospitalization. Sixty patients were followed up for ( 21.8±10.4 ) months. There were 3 new deaths during the 12-month follow-up, 1 due to acute myocardial infarction, 1 due to acute heart failure, and 1 due to severe pneumonia. A total of 55 patients received reviews of CTA of aorta 12 months after operation. Among them, 52 patients had complete aortic arch remodeling, presented as false lumen or intratumoral thrombosis in the area covered by aortic stents. Endoleaks were observed in 3 patients. No acute thrombosis and chronic in-stent restenosis happened in any supra-aortic branch stents. There were no new cases of paraplegia and stroke.Conclusion:TEVAR combined with ISLF is a safe and effective method for the treatment of complex aortic arch lesions, with a high technical success rate and good early prognosis. The application of temporary sheath-based bypass system can effectively protect brain and reduce the incidence of stroke.
What problem does this paper attempt to address?